Tuesday , October 16 2018
Breaking News
Home / HEALTH

HEALTH

The last wish of 3 Siblings…

Once there lived 3 water bottles. All three were sisters – the younger one of 250 ml, the middle one of 500 ml and the eldest of 1000 ml. All the three were very proud to be providing drinkable water to the thirsty throats. But all the three had something ... Read More »

GMCH Successfully carries Whipples Procedure (Surgery)

Udaipur : Oncology surgical team of Geetanjali Cancer Center, Geetanjali Medical College & Hospital, Udaipur were successful in performing the whipple surgery for three patients of age 50, 63 & 75 years respectively hailing from local districts of Rajasthan recently. The patients were referred from local hospitals in view of ... Read More »

Just In: RBI keeps repo rate unchanged at 6.50%

The Reserve Bank of India (RBI), surprising the street expectation of at least a quarter percentage rate hike in its fourth bi-monthly policy announcement, has kept repo rate unchanged at 6.50%. Consequently, the reverse repo rate under the LAF stood at 6.25%, and the marginal standing facility (MSF) rate and ... Read More »

Zydus Cadila gets final approval from USFDA for Exemesfane Tablets

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA)  to market Exemestane Tablets, (US RLD – AROMASIN Tablets), 25 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. The estimated sale for Exemestane Tablets is $68.6 million. Exemestane belongs ... Read More »

Cadila Healthcare’s Biologics manufacturing facility gets EIR from USFDA

Cadila Healthcare’s Biologics manufacturing facility (Zydus Biologics) located at Ahmedabad has received an Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) signifying the successful closure of the audit from August 14 to August 24, 2018, with zero 483 observations. Cadila Healthcare is an India-based pharmaceutical company. The ... Read More »

Lupin launches generic Potassium Chloride Oral Solution

Lupin has launched Potassium Chloride Oral Solution USP, 20 mEq/15mL (10%) and 40 mEq/15 mL (20%), having received an approval from the United States Food and Drug Administration (USFDA) earlier. The company’s Potassium Chloride Oral Solution USP, 20 mEq/15mL (10%) and 40 mEq/15 mL (20%), is the generic equivalent of ... Read More »